TD Capital Management’s Tema Oncology ETF CANC Stock Holding History
Bought
Maintained
Sold
Other funds holding CANC
TD Capital Management's CANC Position: Q3 2026 in Review
TD Capital Management held its Tema Oncology ETF (CANC) position steady in Q3 2026 at 376 shares worth $15.8K. The position accounts for ﹤0.01% of the portfolio, ranked #397.
TD Capital Management first reported a position in CANC in Q3 2025 and has held it in 5 quarters since. 17 funds tracked by Wall St. Rank hold CANC as of Q3 2026.
- TD Capital Management held 376 shares of Tema Oncology ETF worth $15.8K as of Q3 2026.
- TD Capital Management left its Tema Oncology ETF share count unchanged in Q3 2026.
- Tema Oncology ETF made up ﹤0.01% of TD Capital Management's portfolio in Q3 2026, its #397 holding.
- TD Capital Management first reported a position in Tema Oncology ETF in Q3 2025 and has held it in 5 quarters since.
- 17 funds tracked by Wall St. Rank held Tema Oncology ETF as of Q3 2026.
Based on TD Capital Management's 13F filing for Q3 2026, filed 10 Nov 2026.